5Ezekowitz RA,Mulliken JB,Folkman J.Interferon alfa-2a therapy for life-threatening hemangiomas of infancy[J].N Engl J Med,1992,326: 1456-1463. 被引量：1
6Greene AK,Rogers GF,Mulliken JB.Management of parotid hemangioma in 100 children [J].Plast Reconstr Surg, 2004,113: 53-60. 被引量：1
7Blei F,Isakoff M,Deb G.The response of parotid hemangiomas to use of systemic interferon alfa-2a or cortical steroids [J].Arch Otolaryngol Head Neck Surg, 1997,123 (8): 841-844. 被引量：1
8Perez Payarols J,Pardo Masferrer J,Gomez Bellvert C.Treatment of life-threatening infantile hemangiomas with vincristine[J]. N Engl J Med,1995,333(1):69. 被引量：1
9Enjolras O,Mulliken JB, Wassef M.Residual lesions after Kasabach-Merritt phenomenon in 41 patients [J]. J Am Acad Dermatol,2000,42:225-235. 被引量：1
10Haisley-Royster C,Enjolras O, Frieden IJ,et al.Kasabach-Merritt phenomenon: a retrospective study of treatment with vincristine[J].J Pediatr Hematol Oncol,2002,24(6):459-462. 被引量：1
